Chemoinformaics analysis of 5-Hydroxy-3-methoxyphenanthrene-1,4-dione
| Molecular Weight | 254.241 | nRot | 1 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 18 |
| Exact Molecular Weight | 254.058 | nRing | 3 |
| Solubility: LogS | -4.37 | nHRing | 0 |
| Solubility: LogP | 2.743 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 34.9259 |
| nHD | 1 | BPOL | 13.5041 |
| QED | 0.849 |
| Synth | 2.463 |
| Natural Product Likeliness | 1.752 |
| NR-PPAR-gamma | 0.893 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.89 |
| MDCK | 0.0000197 |
| BBB | 0.214 |
| PPB | 0.989796 |
| VDSS | 0.417 |
| FU | 0.0143166 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.776 |
| CYP2c19-inh | 0.883 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.842 |
| CYP2c9-sub | 0.845 |
| CYP2d6-inh | 0.857 |
| CYP2d6-sub | 0.383 |
| CYP3a4-inh | 0.784 |
| CYP3a4-sub | 0.15 |
| CL | 5.682 |
| T12 | 0.381 |
| hERG | 0.02 |
| Ames | 0.891 |
| ROA | 0.922 |
| SkinSen | 0.925 |
| Carcinogencity | 0.929 |
| EI | 0.976 |
| Respiratory | 0.391 |
| NR-Aromatase | 0.391 |
| Antiviral | Yes |
| Prediction | 0.701477 |